Recherche
-
À qui un néphrologue doit-il prescrire un iSGLT2 ? Indications of SGLT2 inhibitors in kidney disease: who, why and when?
(Néphrologie & Thérapeutique. vol. 18, n° 6, Supplement 1, pp. 6S17-6S24, 2022-12-01)Article de revue -
Performance of real-time PCR in suspected haemodialysis catheter-related bloodstream infection: a proof-of-concept study.
(Clinical Kidney Journal. vol. 16, n° 3, pp. 494-500, 2023-03-01)Article de revueLibre accès -
Understanding International Variations in Kidney Failure Incidence and Initiation of Replacement Therapy
(Kidney International Reports. vol. 7, n° 11, pp. 2364-2375, 2022-11-01)Article de revueLibre accès -
Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease
(Journal of the American Medical Directors Association. vol. 23, n° 6, pp. 998-1004.e7, 2022-06-01)Article de revue -
Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
(Frontiers in nutrition. vol. 9, 2022)Article de revueLibre accès -
Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD
(American Journal of Kidney Diseases, 2023-11)Article de revueLibre accès -
PHACTR-1 (Phosphatase and Actin Regulator 1) Deficiency in Either Endothelial or Smooth Muscle Cells Does Not Predispose Mice to Nonatherosclerotic Arteriopathies in 3 Transgenic Mice.
(Arteriosclerosis, Thrombosis, and Vascular Biology. vol. 42, n° 5, pp. 597-609, 2022-05-01)Article de revue -
Urine Protein/Creatinine Ratio in Thrombotic Microangiopathies: A Simple Test to Facilitate Thrombotic Thrombocytopenic Purpura and Hemolytic and Uremic Syndrome Diagnosis
(Journal of clinical medicine. vol. 11, n° 3, 2022-01)Article de revueLibre accès